Vagal nerve TRPV3 regulates sedative-mediated appeasement.
Summary
This mechanistic study identifies TRPV3 in nodose ganglion as a key peripheral sensor through which citronellal and sevoflurane attenuate stress responses via the vagal NG–cNTS glutamatergic pathway. Surgical vagotomy abolished these effects, establishing a causal vagal mechanism for sedative-mediated appeasement.
Key Findings
- Citronellal reduced stress-related anxiety by modulating vagal tone via TRPV3 in nodose ganglion.
- TRPV3 mediated the antistress effects of sevoflurane on heart and respiratory rate hyperactivity.
- Effects required the NG-to-cNTS glutamatergic pathway and were abolished by surgical vagotomy.
Clinical Implications
Suggests that modulating vagal TRPV3 could attenuate stress-related cardiopulmonary hyperactivity during perioperative care and may inform adjunctive nonpharmacologic or pharmacologic anxiolysis approaches.
Why It Matters
It reveals a peripheral, targetable mechanism for sedative effects, linking an inhaled anesthetic (sevoflurane) to vagal TRPV3 signaling. This opens avenues for anxiolysis and sedation strategies that leverage vagal pathways.
Limitations
- Preclinical models; translational relevance and dosing paradigms in humans remain to be established.
- Scope focused on acute stress responses; effects on broader perioperative outcomes need evaluation.
Future Directions
Validate TRPV3–vagal modulation in human studies, quantify effects on perioperative anxiety and autonomic stability, and explore selective TRPV3 modulators as adjuncts to inhaled anesthetics.
Study Information
- Study Type
- Basic/Mechanistic research
- Research Domain
- Pathophysiology
- Evidence Level
- V - Preclinical mechanistic evidence from animal models and pathway interventions.
- Study Design
- OTHER